For research use only. Not for therapeutic Use.
AZ31（Cat No.:I022801）is an experimental compound being studied for its potential in treating cancer and other diseases. It functions by targeting specific signaling pathways that regulate tumor growth, cell proliferation, and survival. AZ31 has shown promise in preclinical studies, demonstrating its ability to inhibit the growth of cancer cells and promote tumor cell death. Research is ongoing to determine its mechanism of action, safety profile, and effectiveness in clinical settings. AZ31 may offer a new treatment option, particularly for cancers that are resistant to existing therapies. Further studies are required to establish its therapeutic potential.
| CAS Number | 2088113-98-6 |
| Synonyms | 6-[6-(methoxymethyl)pyridin-3-yl]-4-[[(1S)-1-(oxan-4-yl)ethyl]amino]quinoline-3-carboxamide |
| Molecular Formula | C24H28N4O3 |
| Purity | ≥95% |
| IUPAC Name | 6-[6-(methoxymethyl)pyridin-3-yl]-4-[[(1S)-1-(oxan-4-yl)ethyl]amino]quinoline-3-carboxamide |
| InChI | InChI=1S/C24H28N4O3/c1-15(16-7-9-31-10-8-16)28-23-20-11-17(18-3-5-19(14-30-2)26-12-18)4-6-22(20)27-13-21(23)24(25)29/h3-6,11-13,15-16H,7-10,14H2,1-2H3,(H2,25,29)(H,27,28)/t15-/m0/s1 |
| InChIKey | DISRGUXSEDBDDN-HNNXBMFYSA-N |
| SMILES | C[C@@H](C1CCOCC1)NC2=C3C=C(C=CC3=NC=C2C(=O)N)C4=CN=C(C=C4)COC |
